https://www.selleckchem.com/products/sd-36.html
Type 2 diabetes mellitus (T2DM) affects 10% of Americans and is associated with an increased incidence of cancer. Statins are first-line cholesterol-lowering medications in the treatment of hyperlipidemia. Several studies have demonstrated a relationship between statin use and reduced cancer incidence. We examined the cancer benefits of statin subtypes, with specific attention to disease-free survival (DFS) and overall survival (OS). This retrospective review included adults with T2DM diagnosed with solid tumors at Roswell Park Cancer Ins
Like
Comment
Share
